Targeted Temperature Management After In-Hospital Cardiac Arrest: An Ancillary Analysis of Targeted Temperature...

Area of Science:

• Neurology
• Critical Care Medicine
• Cardiology

Background:

• Targeted temperature management (TTM) is the sole proven treatment for mitigating brain damage from ischemia-reperfusion injury post-cardiac arrest.
• The efficacy of TTM in patients experiencing in-hospital cardiac arrest (IHCA) remains uncertain.

Purpose of the Study:

• To investigate if TTM at 33°C leads to better neurological outcomes in IHCA patients with nonshockable rhythms compared to targeted normothermia (TN) at 37°C.

Main Methods:

• A post hoc analysis of 159 IHCA patients from a larger randomized trial.
• Patients were randomized to either 33°C (n=73) or 37°C (n=86) for temperature management.
• The primary outcome was survival with good neurological outcome (CPC score 1-2) at 90 days, analyzed using mixed multivariate logistic regression.

Main Results:

• Hypothermia at 33°C for 24 hours was linked to a higher rate of survival with good neurological outcomes (16.4% vs 5.8%, P=.03) compared to TN for 48 hours.
• No significant difference in 90-day mortality was observed between groups (68.5% vs 76.7%, P=.24).
• Adjusted analysis showed hypothermia significantly associated with favorable neurological outcomes (OR, 2.40; P=.03).

Conclusions:

• Hypothermia at 33°C demonstrated improved 90-day neurological outcomes in IHCA patients with nonshockable rhythms versus TN.
• The study's findings suggest a potential benefit of hypothermia for IHCA patients.
• Larger studies are required to confirm these results, especially considering the wide confidence intervals due to the limited sample size.